Police in Vancouver says a man has been arrested for assaulting people on the city's seawall this weekend.
The department says on social media that officers responded to reports of the attacks Saturday.
It says officers were able to find the suspect before anyone was "seriously hurt."
Police say the man has since been charged with four counts of assault.
Photo courtesy of Wikipedia
A new study has found that previous infection with an Omicron variant of COVID-19 did not protect seniors in long-term care and retirement homes from getting reinfected within a few months. Senior author and McMaster University immunologist Dawn Bowdish says the study results are surprising because they challenge the current thinking about hybrid immunity.
The BC Wildfire Service says weather across British Columbia will be impacted by a hurricane in Southern California, challenging firefighters already battling hundreds of fires that forced 30,000 people from their homes and caused a provincial state of emergency.
An air quality advisory for Metro Vancouver remains in place due to wildfire smoke. The Metro Vancouver Regional District says people should postpone or reduce outdoor physical activity particularly if they have underlying conditions related to breathing.
The province's homicide investigation team has been called in after a man was fatally shot in Hope. R-C-M-P say they were called just before 3 a.m. on Sunday and found a 28-year-old man who had been shot and killed.
Newly appointed Health Minister Mark Holland says he doesn't want to go waving a stick around as he negotiates the final details of a health accord with provinces and territories, and it'll largely be up to Canadians to hold them accountable. All provinces except Quebec accepted the $198-billion deal in principle earlier this year and are expected to sign final agreements before the end of 2023.
The province says its PharmaCare program now covers medications used to treat rare diseases such as A-L-S. The Ministry of Health says the oral form of edaravone, which is used to treat A-L-S patients, will be added to the PharmaCare formulary as a limited-coverage benefit.